blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2702409

EP2702409 - CXCR1 as a predictor of response to treatment with epidermal growth factor receptor targeted therapeutic [Right-click to bookmark this link]
Former [2014/10]CXCR1 AS A PREDICTOR OF RESPONSE TO TREATMENT WITH EPIDERMAL GROWTH FACTOR RECEPTOR THERAPEUTIC
[2015/11]
StatusNo opposition filed within time limit
Status updated on  15.07.2016
Database last updated on 03.10.2024
Most recent event   Tooltip19.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 21.11.2018  [2018/47]
Applicant(s)For all designated states
The Queen's University of Belfast
University Road
Belfast BT7 5NN / GB
[2014/10]
Inventor(s)01 / WAUGH, David John James
50 Ballycrochan Avenue
Bangor Down BT19 7LA / GB
02 / WILSON, Richard
23 Cranmore Gardens
Belfast, Antrim BT9 6JL / GB
03 / OLADIPO, Olabode
5A Croft Hill Cottages
Belfast, Antrim BT8 6BA / GB
 [2015/37]
Former [2014/10]01 / WAUGH, David John James
50 Ballycrochan Avenue
Bangor Down BT19 7LA / GB
02 / WILSON, Richard
23 Cranmore Gardens
Belfast, AntrimBT9 6JL / GB
03 / OLADIPO, Olabode
5A Croft Hill Cottages
Belfast, Antrim BT8 6BA / GB
Representative(s)Thom, Russell
Murgitroyd & Company
Scotland House
165-169 Scotland Street
Glasgow G5 8PL / GB
[2014/10]
Application number, filing date12721333.825.04.2012
[2015/37]
WO2012GB50906
Priority number, dateGB2011000687026.04.2011         Original published format: GB 201106870
[2014/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012146919
Date:01.11.2012
Language:EN
[2012/44]
Type: A1 Application with search report 
No.:EP2702409
Date:05.03.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 01.11.2012 takes the place of the publication of the European patent application.
[2014/10]
Type: B1 Patent specification 
No.:EP2702409
Date:09.09.2015
Language:EN
[2015/37]
Search report(s)International search report - published on:EP01.11.2012
ClassificationIPC:G01N33/574, C12Q1/68
[2014/10]
CPC:
C12Q1/6886 (EP,CN,US); G01N33/57484 (EP,CN,US); G01N33/6893 (US);
C12Q2600/106 (EP,CN,US); C12Q2600/158 (EP,CN,US); G01N2333/726 (EP,CN,US);
G01N2800/52 (EP,CN,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/10]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:CXCR1 zur Vorhersage der Reaktion auf die Behandlung mit einem Mittel gegen epidermalen Wachstumsfaktor-Rezeptor[2015/11]
English:CXCR1 as a predictor of response to treatment with epidermal growth factor receptor targeted therapeutic[2015/11]
French:Utilisation de CXCR1 pour prévoir la réponse à un traitement avec agent thérapeutique ciblant le récepteur du facteur de croissance épidermique[2015/11]
Former [2014/10]CXCR1 ALS PRÄDIKTOR DER REAKTION AUF DIE BEHANDLUNG MIT EINEM EPIDERMALEN WACHSTUMSFAKTORREZEPTOR
Former [2014/10]CXCR1 AS A PREDICTOR OF RESPONSE TO TREATMENT WITH EPIDERMAL GROWTH FACTOR RECEPTOR THERAPEUTIC
Former [2014/10]UTILISATION DE CXCR1 POUR PRÉVOIR LA RÉPONSE À UN TRAITEMENT AVEC LE RÉCEPTEUR DU FACTEUR DE CROISSANCE ÉPIDERMIQUE
Entry into regional phase01.11.2013National basic fee paid 
01.11.2013Designation fee(s) paid 
01.11.2013Examination fee paid 
Examination procedure05.02.2013Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.11.2013Examination requested  [2014/10]
10.06.2014Amendment by applicant (claims and/or description)
08.04.2015Communication of intention to grant the patent
17.07.2015Fee for grant paid
17.07.2015Fee for publishing/printing paid
17.07.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.04.2015
Opposition(s)10.06.2016No opposition filed within time limit [2016/33]
Fees paidRenewal fee
30.05.2014Renewal fee patent year 03
30.04.2015Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.04.201403   M06   Fee paid on   30.05.2014
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.04.2012
AL09.09.2015
AT09.09.2015
BE09.09.2015
BG09.09.2015
CY09.09.2015
CZ09.09.2015
DK09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
MK09.09.2015
PL09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
SM09.09.2015
TR09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
PT11.01.2016
LU25.04.2016
MT30.04.2016
[2018/47]
Former [2018/38]HU25.04.2012
AT09.09.2015
BE09.09.2015
BG09.09.2015
CY09.09.2015
CZ09.09.2015
DK09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
MK09.09.2015
PL09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
SM09.09.2015
TR09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
PT11.01.2016
LU25.04.2016
MT30.04.2016
Former [2018/31]HU25.04.2012
AT09.09.2015
BE09.09.2015
CY09.09.2015
CZ09.09.2015
DK09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
MK09.09.2015
PL09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
SM09.09.2015
TR09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
PT11.01.2016
LU25.04.2016
MT30.04.2016
Former [2018/29]HU25.04.2012
AT09.09.2015
BE09.09.2015
CY09.09.2015
CZ09.09.2015
DK09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
MK09.09.2015
PL09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
SM09.09.2015
TR09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
PT11.01.2016
LU25.04.2016
Former [2018/28]HU25.04.2012
AT09.09.2015
BE09.09.2015
CY09.09.2015
CZ09.09.2015
DK09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
MC09.09.2015
MK09.09.2015
PL09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
SM09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
PT11.01.2016
LU25.04.2016
Former [2017/04]AT09.09.2015
BE09.09.2015
CZ09.09.2015
DK09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
PL09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
PT11.01.2016
LU25.04.2016
Former [2017/03]AT09.09.2015
BE09.09.2015
CZ09.09.2015
DK09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
PL09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
PT11.01.2016
Former [2016/39]AT09.09.2015
CZ09.09.2015
DK09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
PL09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
PT11.01.2016
BE30.04.2016
Former [2016/36]AT09.09.2015
CZ09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
PL09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SI09.09.2015
SK09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
PT11.01.2016
BE30.04.2016
Former [2016/24]AT09.09.2015
CZ09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
PL09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SK09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
PT11.01.2016
Former [2016/23]CZ09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
RO09.09.2015
RS09.09.2015
SE09.09.2015
SK09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
Former [2016/22]CZ09.09.2015
EE09.09.2015
FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
RS09.09.2015
SE09.09.2015
NO09.12.2015
GR10.12.2015
IS09.01.2016
Former [2016/11]FI09.09.2015
HR09.09.2015
LT09.09.2015
LV09.09.2015
RS09.09.2015
SE09.09.2015
NO09.12.2015
GR10.12.2015
Former [2016/09]FI09.09.2015
LT09.09.2015
LV09.09.2015
NO09.12.2015
GR10.12.2015
Former [2016/08]LT09.09.2015
NO09.12.2015
Former [2016/07]LT09.09.2015
Cited inInternational search[A]US2007128636  (BAKER JOFFRE B [US], et al);
 [YA]US2009258364  (GOEL SANJAY [US], et al);
 [Y]WO2010145796  (MERCK PATENT GMBH [DE], et al);
 [XY]US2011053787  (BRULLIARD MARIE [FR], et al)
by applicantWO9116051
 US5196446
 US5558864
 WO9630347
 WO9633980
 US5616582
 US5646153
 WO9727199
 US5656655
 WO9730034
 US5679683
 WO9742187
 WO9749688
 WO9833798
 US5891996
 WO0018761
 WO0031048
 US6235883
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.